tetano
Editor, Senior Moderator
Clin Transl Immunology
. 2021 Jun 13;10(6):e1297.
doi: 10.1002/cti2.1297. eCollection 2021.
Repeated influenza vaccination provides cumulative protection from distinct H3N2 viruses
Niloufar Kavian[SUP] 1 2 3 4 [/SUP], Asmaa Hachim[SUP] 1 2 [/SUP], Benjamin J Cowling[SUP] 2 [/SUP], Sophie A Valkenburg[SUP] 1 2 [/SUP]
Affiliations
Abstract
Objectives: Current inactivated influenza vaccines provide suboptimal protection against antigenic drift, and repeated annual vaccinations shape antibody specificity but the effect on protection from infection is not well understood.
Methods: We studied the effects of cumulative and staggered vaccinations in mice to determine the effect of influenza vaccination on protection from infection and immune quality.
Results: We found that the timing of vaccination and antigenic change impacted the quality of immune responses. When mice received two different H3N2 strains (A/Hong Kong/4801/2014 and A/Singapore/INFIMH-16-0019/2016) by staggered timing of vaccination, there were higher H3HA antibody and B-cell memory responses than four cumulative vaccinations or when two vaccinations were successive. Interestingly, after challenge with a lethal-drifted H3N2 virus (A/Hong Kong/1/1968), mice with staggered vaccination were unable to produce high titres of antibodies specific to the challenge strain compared to other vaccination regimens because of high levels of vaccine-specific cross-reactive antibodies. All vaccination regimens resulted in protection, in terms of viral loads and survival, from lethal challenge, while lung IL-6 and inflammation were lowest in staggered or cumulative vaccination groups, indicating further advantage.
Conclusion: Our findings help justify influenza vaccination policies that currently recommend repeat vaccination in infants and annual seasonal vaccination, with no evidence for impaired immunity by repeated seasonal vaccination.
Keywords: antibodies; cross‐protection; immune imprinting; influenza virus; repeated vaccination.
. 2021 Jun 13;10(6):e1297.
doi: 10.1002/cti2.1297. eCollection 2021.
Repeated influenza vaccination provides cumulative protection from distinct H3N2 viruses
Niloufar Kavian[SUP] 1 2 3 4 [/SUP], Asmaa Hachim[SUP] 1 2 [/SUP], Benjamin J Cowling[SUP] 2 [/SUP], Sophie A Valkenburg[SUP] 1 2 [/SUP]
Affiliations
- PMID: 34136219
- PMCID: PMC8200319
- DOI: 10.1002/cti2.1297
Abstract
Objectives: Current inactivated influenza vaccines provide suboptimal protection against antigenic drift, and repeated annual vaccinations shape antibody specificity but the effect on protection from infection is not well understood.
Methods: We studied the effects of cumulative and staggered vaccinations in mice to determine the effect of influenza vaccination on protection from infection and immune quality.
Results: We found that the timing of vaccination and antigenic change impacted the quality of immune responses. When mice received two different H3N2 strains (A/Hong Kong/4801/2014 and A/Singapore/INFIMH-16-0019/2016) by staggered timing of vaccination, there were higher H3HA antibody and B-cell memory responses than four cumulative vaccinations or when two vaccinations were successive. Interestingly, after challenge with a lethal-drifted H3N2 virus (A/Hong Kong/1/1968), mice with staggered vaccination were unable to produce high titres of antibodies specific to the challenge strain compared to other vaccination regimens because of high levels of vaccine-specific cross-reactive antibodies. All vaccination regimens resulted in protection, in terms of viral loads and survival, from lethal challenge, while lung IL-6 and inflammation were lowest in staggered or cumulative vaccination groups, indicating further advantage.
Conclusion: Our findings help justify influenza vaccination policies that currently recommend repeat vaccination in infants and annual seasonal vaccination, with no evidence for impaired immunity by repeated seasonal vaccination.
Keywords: antibodies; cross‐protection; immune imprinting; influenza virus; repeated vaccination.